Jean-Marc Bellemin
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jean-Marc Bellemin
Jean-Marc Bellemin is recorded as CFO at Iovance Biotherapeutics, Inc. (IOVA). Iovance Biotherapeutics, Inc. reported in an 8-K filed July 3, 2025 that Jean-Marc Bellemin resigned as Chief Financial Officer and Principal Financial Officer and Principal Accounting Officer, effective June 30, 2025. Iovance Biotherapeutics, Inc. reported in an 8-K filed June 13, 2025 that Jean-Marc Bellemin resigned as Chief Financial Officer and principal financial and accounting officer, effective July 10, 2025. Jean-Marc Bellemin has spoken on 18 earnings calls across 1 company, most recently for Iovance Biotherapeutics, Inc. on May 8, 2025.
“On June 30, 2025, the Company and Mr. Bellemin mutually agreed that Mr. Bellemin would separate from the Company, effective June 30, 2025.”
“On June 10, 2025, Jean-Marc Bellemin, the Chief Financial Officer and principal financial and accounting officer of Iovance Biotherapeutics, Inc. (the "Company"), provided the Company with written notice under his Executive Employment Agreement, dated November 23, 2020, that he would resign from the Company, effective July 10, 2025, to pursue other opportunities.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2025-07-10
-
Start not stated–2025-06-30
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Iovance Biotherapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Frederick G. Vogt, Ph.D. CEO
- Frederick Vogt CEO, General Counsel
- Corleen Roche CFO
- Igor Bilinsky COO
- Igor Bilinsky, Ph.D. COO
- Matthew W. Rosinack Chief Accounting Officer
- Michael C. Swartzburg Chief Accounting Officer
- Athena Countouriotis Board Member
- Iain Dukes Board Member
- Maria Fardis Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.